RxUtility Launches Personalized AI Companion Mimi™ to Compare Every Drug Price as Affordability Crisis Grows
RxUtility, the medication affordability platform, today announced the beta launch of Mimi™, the healthcare industry’s most comprehensive AI companion to help people navigate the full range of medication cost options. Free for everyone to use during the beta period, Mimi guides consumers through a personalized conversation to ensure they have every available option in front of them. Users make AI-informed decisions with confidence, based on their insurance coverage, location, and budget.
RxUtility and Buzz Health Partner to Boost Medication Price Transparency for Consumers
RxUtility, a real-time medication affordability toolkit, today announced a new partnership with Buzz Health, leveraging its RxCompare multi-discount card pricing API. Through this partnership, cash discounts and copay coupons will be directly integrated into pharmacy, provider, and other healthcare systems, giving users greater price transparency at the points of prescribing and fulfillment while offering patients more control over cost options.
Americans Abandon 98 Million Prescriptions Annually Due to Cost, Finds New RxUtility Report
RxUtility’s “2025 Medication Affordability Benchmark Report” shows patients starting new therapy abandon 98 million prescriptions due to their unexpected high costs. There are often more affordable options, yet most patients have no easy way to find them.
New Report from RxUtility: The U.S. Healthcare System Is Losing the Fight for Medication Affordability
In a report released today, RxUtility reveals new data that shows how the U.S. healthcare system is behind in the fight for medication affordability. As patients face skyrocketing out-of-pocket costs and contradictory information around pricing, data shows more than $30 billion in annual manufacturer prescription copay assistance is available, while only 10 percent of these coupons are ever used.
